Life ScienceCompany
Green Cross Biotherapeutics Ownership
Who owns Green Cross Biotherapeutics?
Green Cross Biotherapeutics is owned by Stonebridge Capital. It was acquired on January 1, 2015.
Is Green Cross Biotherapeutics PE-backed?
Yes. Green Cross Biotherapeutics is owned by private equity investor Stonebridge Capital.
Green Cross Biotherapeutics Business Overview
Where is Green Cross Biotherapeutics headquartered?
Green Cross Biotherapeutics is headquartered in Montreal, Quebec.
What sector is Green Cross Biotherapeutics in?
Green Cross Biotherapeutics is a life science company.
Life Science M&A Summary in 2015
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.
Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.